HealthInsight

healthinsight.org

HealthInsight is a nonprofit, community-based health care consulting organization dedicated to improving health and health care. HealthInsight has more than 40 years of experience assisting front-line providers and engaging health care stakeholders. Our services improve outcomes and deliver measureable results that directly influence the care delivered to millions of people.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

GENE THERAPY OFFERS HOPE FOR UNTREATABLE CTE BRAIN DISORDER

Genetic Literacy Project | January 14, 2020

news image

Researchers from Weill Cornell Medical College published a new study (“Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy”) in Human Gene Therapy that shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE). The study demonstrated the effectiveness of direct delivery of gene therapy into the brain of a mouse model of CTE....

Read More

INDUSTRIAL IMPACT

ORION BIOTECHNOLOGY AND PEPTILOGICS ENTER STRATEGIC RESEARCH COLLABORATION TO ENABLE AI-DRIVEN DRUG DISCOVERY AGAINST UNDRUGGED GPCR TARGET

Orion Biotechnology | July 15, 2022

news image

Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors and Peptilogics, a biotech company engineering peptide therapeutics by combining computation and biology to improve the treatment landscape for patients with life-threatening diseases, announced today that they have entered a research and development collaboration to leverage AI for drug discovery against an undrugged GPCR target. The collaboration will combine the...

Read More

EUROPEAN PATENT OFFICE GRANTS CELLECT BIOTECHNOLOGY PIVOTAL PATENT FOR STEM CELLS ACTIVATION

Cellect Biotechnology | August 10, 2020

news image

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application No. 14851547.1 has been granted. The patent will be set to expire in October 7, 2034, subject to patent term adjustment or extension."This is a pivotal event for Cellect and perhaps one of the most crucial developments for us&nb...

Read More

CORONAVIRUS VACCINES ARE MOVING TOWARDS CLINICAL TRIALS, PROMISES SEVERAL BIOTECH COMPANIES IN THE US

Edex Live | April 09, 2020

news image

Just three months after the outbreak of the coronavirus pandemic, several biotech companies in the United States have ramped up their efforts to fight the disease with accelerated schedules for creating new vaccines and beginning clinical trials for potential treatments. In normal circumstances, vaccine development would take around 10 years. But the pharmaceutical industry is racing to compress this timeline with the support of non-profit organisations, government agencies and regulatory author...

Read More
news image

GENE THERAPY OFFERS HOPE FOR UNTREATABLE CTE BRAIN DISORDER

Genetic Literacy Project | January 14, 2020

Researchers from Weill Cornell Medical College published a new study (“Anti-Phospho-Tau Gene Therapy for Chronic Traumatic Encephalopathy”) in Human Gene Therapy that shows the feasibility of using gene therapy to treat the progressive neurodegenerative disorder chronic traumatic encephalopathy (CTE). The study demonstrated the effectiveness of direct delivery of gene therapy into the brain of a mouse model of CTE....

Read More
news image

INDUSTRIAL IMPACT

ORION BIOTECHNOLOGY AND PEPTILOGICS ENTER STRATEGIC RESEARCH COLLABORATION TO ENABLE AI-DRIVEN DRUG DISCOVERY AGAINST UNDRUGGED GPCR TARGET

Orion Biotechnology | July 15, 2022

Orion Biotechnology Canada Ltd, a drug discovery company targeting previously undruggable G Protein-Coupled Receptors and Peptilogics, a biotech company engineering peptide therapeutics by combining computation and biology to improve the treatment landscape for patients with life-threatening diseases, announced today that they have entered a research and development collaboration to leverage AI for drug discovery against an undrugged GPCR target. The collaboration will combine the...

Read More
news image

EUROPEAN PATENT OFFICE GRANTS CELLECT BIOTECHNOLOGY PIVOTAL PATENT FOR STEM CELLS ACTIVATION

Cellect Biotechnology | August 10, 2020

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced that it has significantly strengthened its Intellectual Property (IP) portfolio as European Patent Application No. 14851547.1 has been granted. The patent will be set to expire in October 7, 2034, subject to patent term adjustment or extension."This is a pivotal event for Cellect and perhaps one of the most crucial developments for us&nb...

Read More
news image

CORONAVIRUS VACCINES ARE MOVING TOWARDS CLINICAL TRIALS, PROMISES SEVERAL BIOTECH COMPANIES IN THE US

Edex Live | April 09, 2020

Just three months after the outbreak of the coronavirus pandemic, several biotech companies in the United States have ramped up their efforts to fight the disease with accelerated schedules for creating new vaccines and beginning clinical trials for potential treatments. In normal circumstances, vaccine development would take around 10 years. But the pharmaceutical industry is racing to compress this timeline with the support of non-profit organisations, government agencies and regulatory author...

Read More

Resources

resource image

INDUSTRIAL IMPACT

The US Bioeconomy

Whitepaper

resource image

CELL AND GENE THERAPY

Gene, Cell, & RNA Therapy Landscape

Whitepaper

resource image

CELL AND GENE THERAPY

Lipid Nanoparticle and Liposome

Whitepaper

resource image

CELL AND GENE THERAPY

Automated Microbioreactor Technology

Video

resource image

INDUSTRIAL IMPACT

The US Bioeconomy

Whitepaper

resource image

CELL AND GENE THERAPY

Gene, Cell, & RNA Therapy Landscape

Whitepaper

resource image

CELL AND GENE THERAPY

Lipid Nanoparticle and Liposome

Whitepaper

resource image

CELL AND GENE THERAPY

Automated Microbioreactor Technology

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us